Chemical genetics approach to hepatitis C virus replication: cyclophilin as a target for anti-hepatitis C virus strategy.
about
Chaperones in hepatitis C virus infectionA Locking Mechanism Regulates RNA Synthesis and Host Protein Interaction by the Hepatitis C Virus PolymeraseAcetylation regulates Cyclophilin A catalysis, immunosuppression and HIV isomerizationHepatitis B virus (HBV) surface antigen interacts with and promotes cyclophilin a secretion: possible link to pathogenesis of HBV infectionChemical genetics.Natural products as promising drug candidates for the treatment of hepatitis B and C.New antiviral therapies for chronic hepatitis CScreening compounds against HCV based on MAVS/IFN-β pathway in a replicon modelHepatitis C virus NS5A inhibitors and drug resistance mutations.Proteomic analysis of host brain components that bind to infectious particles in Creutzfeldt-Jakob disease.Hepatitis C virus virology and new treatment targets.Antiviral activity of Acacia nilotica against Hepatitis C Virus in liver infected cellsHepatitis C virus as a multifaceted disease: a simple and updated approach for extrahepatic manifestations of hepatitis C virus infectionCyclophilin inhibitors in hepatitis C viral infection.Influenza virus-host interactomes as a basis for antiviral drug development.Efficacy of antiviral therapy for hepatitis C after liver transplantation with cyclosporine and tacrolimus: a systematic review and meta-analysis.Effect of maintenance immunosuppressive drugs on virus pathobiology: evidence and potential mechanisms.Recurrent hepatitis C virus infection post liver transplantation: impact of choice of calcineurin inhibitor.An update on the management of hepatitis C virus-related arthritis.Chemical genetics-based development of small molecules targeting hepatitis C virus.Anti-hepatitis C virus activity of tamoxifen reveals the functional association of estrogen receptor with viral RNA polymerase NS5B.HCV NS5A resistance-associated variants in a group of real-world Japanese patients chronically infected with HCV genotype 1b.Specifically targeted antiviral therapy for hepatitis C virus.
P2860
Q26771251-ECFE8031-D26D-4EB3-AC8C-A57ECA01D922Q27486419-0CAF32DD-1D54-4CDF-8DCB-3D187DF2CE85Q27660416-D837B49E-6E51-414F-B8A4-CDA5623690D3Q33725558-A6A2FF57-84EF-4D3A-9AB0-C477F836D493Q33896011-68750624-C31E-49B9-98BD-446483F16D5AQ34015041-A78EA21B-EF20-4493-A3B1-76EEABC3C2E4Q34130399-75053F28-845A-44EB-86FA-6089ECEEE38EQ34354669-10A68A76-434F-4408-AA4D-C9607C645601Q34411617-7532E74F-B663-4076-AA79-FD43ADA1D005Q34474526-9D127576-658B-473E-8641-7D3C52AB828BQ34974042-46570FFF-EDB1-436B-B921-F6EAB7B8A186Q35047714-A38F5FB4-0BE3-491B-8577-567717A5F029Q35731058-52DCCA07-8E05-4A8D-A785-A50911D68AC5Q36916858-9C8AECCF-DA46-4493-A1AA-52A0E8743D4AQ37737812-E92D6508-643D-4DAC-906E-3AC6811B896EQ38028429-3FBCB0B6-C3B3-4763-8704-35D8C661A1ADQ38061056-25B9F794-89B8-490D-A87E-043FC38C8640Q38081919-673F146E-FD34-478A-997B-1AB98AE982FEQ38242116-166A0CF8-4BB2-4FC0-8D51-3BE2620B13FFQ40063790-7E1C0E18-1E29-4AD3-B4B4-84D762CA8412Q40092859-64AF032A-1CB1-4B60-A78E-6A958CFFB2F2Q41407052-76B06922-B367-4DF5-A6BD-DAF442C1F6DDQ42909514-E097C74F-C1FF-4A22-B53E-CD61E1237302
P2860
Chemical genetics approach to hepatitis C virus replication: cyclophilin as a target for anti-hepatitis C virus strategy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Chemical genetics approach to ...... ti-hepatitis C virus strategy.
@ast
Chemical genetics approach to ...... ti-hepatitis C virus strategy.
@en
type
label
Chemical genetics approach to ...... ti-hepatitis C virus strategy.
@ast
Chemical genetics approach to ...... ti-hepatitis C virus strategy.
@en
prefLabel
Chemical genetics approach to ...... ti-hepatitis C virus strategy.
@ast
Chemical genetics approach to ...... ti-hepatitis C virus strategy.
@en
P356
P1476
Chemical genetics approach to ...... ti-hepatitis C virus strategy.
@en
P2093
Koichi Watashi
Kunitada Shimotohno
P304
P356
10.1002/RMV.534
P577
2007-07-01T00:00:00Z